Keyphrases
Host Response
100%
Translocated
100%
Outcome Prediction
100%
Microbial Products
100%
HCV Infection
100%
Soluble CD14 (sCD14)
100%
HBV Infection
100%
Cirrhosis
75%
Fibrosis
75%
Lipopolysaccharide
75%
Plasma Parameters
75%
Monocytes
50%
Interleukin-6
50%
Enterocyte
50%
I-FABP
50%
Infected Individual
25%
Hepatitis C Virus
25%
Liver Disease
25%
Chronic Infection
25%
Ferritin
25%
Pathogenic Mechanism
25%
Enzyme-linked Immunosorbent Assay (ELISA)
25%
Alpha-fetoprotein
25%
Disease Progression
25%
Lipopolysaccharide-induced
25%
Systemic Inflammation
25%
Antiviral Treatment
25%
Aspartate Aminotransferase
25%
Systemic Circulation
25%
Alkaline Phosphatase
25%
Increased Intestinal Permeability
25%
Local Inflammation
25%
End-stage Liver Disease
25%
Kupffer Cells
25%
Microbial Translocation
25%
Bacterial Overgrowth
25%
Gut Microbial Community
25%
Glutamyl Transpeptidase
25%
Hepatitis B Virus
25%
Portal Hypertension
25%
Hepatic Inflammation
25%
Chronic HBV Infection
25%
Chronic HCV Infection
25%
Low Platelet Count
25%
CD14+ Cells
25%
Limulus Amebocyte Lysate Assay
25%
Severe Fibrosis
25%
Medicine and Dentistry
Infection
100%
Immune Response
100%
Hepatitis B Virus
100%
Fibrosis
66%
Lipopolysaccharide
66%
Liver Cirrhosis
50%
Interleukin 6
33%
Fatty Acid Binding Protein 2
33%
Gut
16%
Liver Disease
16%
Volunteer
16%
Ferritin
16%
Enzyme Linked Immunosorbent Assay
16%
Retrospective Study
16%
Alkaline Phosphatase
16%
Hepatitis C Virus
16%
Disease Exacerbation
16%
Antiviral Therapy
16%
Aspartate Aminotransferase
16%
End Stage Liver Disease
16%
Fetoprotein
16%
Kupffer Cell
16%
Bacterial Overgrowth
16%
Intestinal Permeability
16%
Portal Hypertension
16%
Systemic Circulation
16%
Gamma-Glutamyl Transpeptidase
16%
Low Platelet Count
16%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Hepatitis B Virus
100%
Fibrosis
66%
Lipopolysaccharide
66%
Liver Cirrhosis
50%
Inflammation
33%
Interleukin 6
33%
Fatty Acid Binding Protein 2
33%
Enzyme-Linked Immunosorbent Assay
16%
Antivirus Agent
16%
Liver Disease
16%
Hepatitis C Virus
16%
Retrospective Study
16%
Disease Exacerbation
16%
Aspartate Aminotransferase
16%
Intestinal Permeability
16%
Fetoprotein
16%
Ferritin
16%
End Stage Liver Disease
16%
Gamma Glutamyltransferase
16%
Alkaline Phosphatase
16%
Systemic Circulation
16%
Portal Hypertension
16%
Limulus
16%
Immunology and Microbiology
Immune Response
100%
Hepatitis B Virus
100%
CD14
83%
Blood Level
50%
Protein Binding
33%
Interleukin 6
33%
Hepatitis C Virus
16%
Systemic Inflammation
16%
Cell Lysate
16%
Enzyme-Linked Immunosorbent Assay
16%
Platelet Count
16%
Bacterial Overgrowth
16%
Kupffer Cell
16%
Systemic Circulation
16%
Limulus
16%
Ferritin
16%